Read More Pharma Industry News Positive IDWeek 2025 results highlight Armata’s AP-SA02 phage cocktail as a potential game-changer for Staph bacteremia Find out how Armata Pharmaceuticals’ AP-SA02 phage therapy could redefine treatment for Staphylococcus aureus bloodstream infections. bySoujanya RaviOctober 22, 2025